142 related articles for article (PubMed ID: 31671125)
1. Analytic performance of PANArray HPV and HPV 9G DNA chip tests for genotyping of high-risk human papillomavirus in cervical ThinPrep PreservCyt samples.
Kim J; Jun SY
PLoS One; 2019; 14(10):e0224483. PubMed ID: 31671125
[TBL] [Abstract][Full Text] [Related]
2. The clinical performance of human papillomavirus genotyping using PANArray HPV chip: Comparison to ThinPrep cytology alone and co-testing.
Kim J; Jun SY; Maeng LS
Pathol Res Pract; 2020 Sep; 216(9):153121. PubMed ID: 32825927
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Analytical and Clinical Performance of HPV 9G DNA Chip, PANArray HPV Genotyping Chip, and Hybrid-Capture II Assay in Cervicovaginal Swabs.
Jung HY; Han HS; Kim HB; Oh SY; Lee SJ; Kim WY
J Pathol Transl Med; 2016 Mar; 50(2):138-46. PubMed ID: 26763506
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women.
Ki EY; Lee YK; Lee A; Park JS
Yonsei Med J; 2018 Jul; 59(5):662-668. PubMed ID: 29869464
[TBL] [Abstract][Full Text] [Related]
5. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Cobas 4800 HPV and HPV 9G DNA Chip Tests for Detection of High-Risk Human Papillomavirus in Cervical Specimens of Women with Consecutive Positive HPV Tests But Negative Pap Smears.
Jun SY; Park ES; Kim J; Kang J; Lee JJ; Bae Y; Kim SI; Maeng LS
PLoS One; 2015; 10(10):e0140336. PubMed ID: 26469982
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the digene HPV genotyping LQ test and the PANArray HPV genotyping chip for detection of high-risk or probable high-risk human papillomavirus genotypes.
Park KS; Kim JY; Ki CS; Lee NY
Ann Lab Med; 2014 Jul; 34(4):279-85. PubMed ID: 24982832
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
Park Y; Lee E; Choi J; Jeong S; Kim HS
J Clin Microbiol; 2012 Jul; 50(7):2359-65. PubMed ID: 22518863
[TBL] [Abstract][Full Text] [Related]
9. Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing.
Wagner S; Roberson D; Boland J; Yeager M; Cullen M; Mirabello L; Dunn ST; Walker J; Zuna R; Schiffman M; Wentzensen N
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30814267
[TBL] [Abstract][Full Text] [Related]
10. Clinical performance assessment of five human papillomavirus DNA tests using liquid-based cytology samples.
Song SH; Hong JH; Kwak SH; Lee JK; Kim MK
J Obstet Gynaecol Res; 2012 Feb; 38(2):408-14. PubMed ID: 22175246
[TBL] [Abstract][Full Text] [Related]
11. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
12. Detection and genotyping of human papillomavirus by five assays according to cytologic results.
Choi J; Park Y; Lee EH; Kim S; Kim JH; Kim HS
J Virol Methods; 2013 Jan; 187(1):79-84. PubMed ID: 22982075
[TBL] [Abstract][Full Text] [Related]
13. HPV 9G DNA chip: 100% clinical sensitivity and specificity.
An H; Song KS; Nimse SB; Kim J; Nguyen VT; Ta VT; Sayyed DR; Kim T
J Clin Microbiol; 2012 Mar; 50(3):562-8. PubMed ID: 22170909
[TBL] [Abstract][Full Text] [Related]
14. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.
Binnicker MJ; Pritt BS; Duresko BJ; Espy MJ; Grys TE; Zarka MA; Kerr SE; Henry MR
J Clin Microbiol; 2014 Oct; 52(10):3763-8. PubMed ID: 25122861
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.
Moussavou-Boundzanga P; Koumakpayi IH; Labouba I; Leroy EM; Belembaogo E; Berthet N
Virol J; 2017 Dec; 14(1):241. PubMed ID: 29268766
[TBL] [Abstract][Full Text] [Related]
17. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.
Carozzi F; Bisanzi S; Sani C; Zappa M; Cecchini S; Ciatto S; Confortini M
J Clin Microbiol; 2007 Feb; 45(2):364-9. PubMed ID: 17122008
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting.
Padalko E; Ali-Risasi C; Mesmaekers S; Ryckaert I; Van Renterghem L; Lambein K; Bamelis M; De Mey A; Sturtewagen Y; Vastenavond H; Broeck DV; Weyers S; Praet M
Eur J Cancer Prev; 2015 Sep; 24(5):447-53. PubMed ID: 25370681
[TBL] [Abstract][Full Text] [Related]
20. Human papillomaviruses other than 16, 18 and 45 are the major high risk HPV genotypes amongst women with abnormal cervical smear cytology residing in Kuwait: Implications for future vaccination strategies.
Mallik MK; Alramadhan B; Dashti H; Al-Shaheen A; Al Juwaiser A; Das DK; George SS; Kapila K
Diagn Cytopathol; 2018 Dec; 46(12):1036-1039. PubMed ID: 30353685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
